Loading...
Wakamoto Pharmaceutical Co.,Ltd.
4512.T•JPX
Healthcare
Drug Manufacturers - Specialty & Generic
¥297.00
¥0.00(0.00%)
Wakamoto Pharmaceutical Co.,Ltd. (4512.T) AI-Powered Stock Analysis
See how Wakamoto Pharmaceutical Co.,Ltd. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerWakamoto Pharmaceutical Co.,Ltd. (4512.T) Stock Overall Grade
Wakamoto Pharmaceutical Co.,Ltd.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Wakamoto Pharmaceutical Co.,Ltd.'s overall stock rating.
Forecast
A+Score
100/100Financial Growth
BScore
60/100Fundamental Growth
DScore
38/100Key Ratios
BScore
64/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Wakamoto Pharmaceutical Co.,Ltd. (4512.T) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 100/100 (A+), reflecting high confidence in its potential. Financial Growth (60/100, B) and Fundamental Growth (38/100, D) highlight its stability, while Key Ratios (64/100, B) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Wakamoto Pharmaceutical Co.,Ltd. stock grade, including financials, comparisons, and forecasts.